{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T01:45:42Z","timestamp":1790214342481,"version":"4.1.0"},"reference-count":52,"publisher":"American Physiological Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Journal of Physiology-Cell Physiology"],"published-print":{"date-parts":[[2008,4]]},"abstract":"<jats:p> Malignant hyperthermia (MH) susceptibility is a genetic disorder of skeletal muscle associated with mutations in the ryanodine receptor isoform 1 (RyR1) of sarcoplasmic reticulum (SR). In MH-susceptible skeletal fibers, RyR1-mediated Ca<jats:sup>2+<\/jats:sup> release is highly sensitive to activation by the volatile anesthetic halothane. Indeed, studies with isolated RyR1 channels (using simple Cs<jats:sup>+<\/jats:sup> solutions) found that halothane selectively affects mutated but not wild-type RyR1 function. However, studies in skeletal fibers indicate that halothane can also activate wild-type RyR1-mediated Ca<jats:sup>2+<\/jats:sup> release. We hypothesized that endogenous RyR1 agonists (ATP, lumenal Ca<jats:sup>2+<\/jats:sup>) may increase RyR1 sensitivity to halothane. Consequently, we studied how these agonists affect halothane action on rabbit skeletal RyR1 reconstituted into planar lipid bilayers. We found that cytosolic ATP is required for halothane-induced activation of the skeletal RyR1. Unlike RyR1, cardiac RyR2 (much less sensitive to ATP) responded to halothane even in the absence of this agonist. ATP-dependent halothane activation of RyR1 was enhanced by cytosolic Ca<jats:sup>2+<\/jats:sup> (channel agonist) and counteracted by Mg<jats:sup>2+<\/jats:sup> (channel inhibitor). Dantrolene, a muscle relaxant used to treat MH episodes, did not affect RyR1 or RyR2 basal activity and did not interfere with halothane-induced activation. Studies with skeletal SR microsomes confirmed that halothane-induced RyR1-mediated SR Ca<jats:sup>2+<\/jats:sup> release is enhanced by high ATP-low Mg<jats:sup>2+<\/jats:sup> in the cytosol and by increased SR Ca<jats:sup>2+<\/jats:sup> load. Thus, physiological or pathological processes that induce changes in cellular levels of these modulators could affect RyR1 sensitivity to halothane in skeletal fibers, including the outcome of halothane-induced contracture tests used to diagnose MH susceptibility. <\/jats:p>","DOI":"10.1152\/ajpcell.90642.2007","type":"journal-article","created":{"date-parts":[[2008,2,28]],"date-time":"2008-02-28T02:51:05Z","timestamp":1204167065000},"page":"C1103-C1112","source":"Crossref","is-referenced-by-count":33,"title":["Halothane modulation of skeletal muscle ryanodine receptors: dependence on Ca<sup>2+<\/sup>, Mg<sup>2+<\/sup>, and ATP"],"prefix":"10.1152","volume":"294","author":[{"given":"Paula L.","family":"Diaz-Sylvester","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura","family":"Porta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio A.","family":"Copello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"24","reference":[{"key":"R1","doi-asserted-by":"crossref","unstructured":"Allen GC, Larach MG, Kunselman AR. The sensitivity and specificity of the caffeine-halothane contracture test. A report from the North American Malignant Hyperthermia Registry The North American Malignant Hyperthermia Registry of MHAUS. Anesthesiology 88: 579\u2013588, 1998.","DOI":"10.1097\/00000542-199803000-00006"},{"key":"R2","doi-asserted-by":"crossref","unstructured":"Avila G. Intracellular Ca2+ dynamics in malignant hyperthermia and central core disease: established concepts, new cellular mechanisms involved. Cell Calcium 37: 121\u2013127, 2005.","DOI":"10.1016\/j.ceca.2004.08.001"},{"key":"R3","doi-asserted-by":"crossref","unstructured":"Chamberlain BK, Levitsky DO, Fleischer S. Isolation and characterization of canine cardiac sarcoplasmic reticulum with improved Ca2+ transport properties. J Biol Chem 258: 6602\u20136609, 1983.","DOI":"10.1016\/S0021-9258(18)32455-4"},{"key":"R4","doi-asserted-by":"crossref","unstructured":"Cherednichenko G, Ward CW, Feng W, Cabrales E, Michaelson L, Samso M, Lopez JR, Allen PD, Pessah IN. Enhanced excitation-coupled calcium entry (ECCE) in myotubes expressing malignant hyperthermia mutation R163C is attenuated by dantrolene. Mol Pharmacol. 2008 Jan 2; [Epub ahead of print].","DOI":"10.1124\/mol.107.043299"},{"key":"R5","doi-asserted-by":"crossref","unstructured":"Connelly TJ, Coronado R. Activation of the Ca2+ release channel of cardiac sarcoplasmic reticulum by volatile anesthetics. Anesthesiology 81: 459\u2013469, 1994.","DOI":"10.1097\/00000542-199408000-00025"},{"key":"R6","doi-asserted-by":"crossref","unstructured":"Copello JA, Barg S, Onoue H, Fleischer S. Heterogeneity of Ca2+ gating of skeletal muscle ryanodine receptor (RyR-1) compared with cardiac RyR-2. Biophys J 73: 141\u2013156, 1997.","DOI":"10.1016\/S0006-3495(97)78055-X"},{"key":"R7","doi-asserted-by":"crossref","unstructured":"Copello JA, Barg S, Sonnleitner A, Porta M, Diaz-Sylvester PL, Fill M, Schindler H, Fleischer S. Mg2+ block of cardiac and skeletal muscle ryanodine receptors. Effects of Ca2+, ATP and caffeine. J Membr Biol 187: 51\u201364, 2002.","DOI":"10.1007\/s00232-001-0150-x"},{"key":"R8","doi-asserted-by":"crossref","unstructured":"Denborough MA, Warne GL, Moulds RF, Martin FI. Insulin secretion in malignant hyperpyrexia. Br Med J 3: 493\u2013495, 1974.","DOI":"10.1136\/bmj.3.5929.493"},{"key":"R9","unstructured":"Diaz-Sylvester PL, Porta M, Fill M, Copello JA. Halothane action on skeletal muscle ryanodine receptor (RyR1) channels (Abstract). Biophys J 88: 485A\u2013486A, 2005."},{"key":"R10","unstructured":"Diaz-Sylvester PL, Porta M, Nani A, Escobar A, Fill M, Copello JA. Modulation of cardiac ryanodine receptors (RyR2) by divalent cations M(2+) (Abstract). Biophys J 82: 361A, 2002."},{"key":"R11","doi-asserted-by":"crossref","unstructured":"Duke AM, Hopkins PM, Steele DS. Effects of Mg+2 and SR luminal Ca2+ on caffeine-induced Ca2+ release in skeletal muscle from humans susceptible to malignant hyperthermia. J Physiol 544: 85\u201395, 2002.","DOI":"10.1113\/jphysiol.2002.022749"},{"key":"R12","doi-asserted-by":"crossref","unstructured":"Duke AM, Hopkins PM, Steele DS. Mg2+ dependence of halothane-induced Ca2+ release form the sarcoplasmic reticulum in rat skeletal muscle. J Physiol 551: 447\u2013454, 2003.","DOI":"10.1113\/jphysiol.2003.046623"},{"key":"R13","doi-asserted-by":"crossref","unstructured":"el-Hayek R, Parness J, Valdivia HH, Coronado R, Hogan K. Dantrolene and azumolene inhibit [3H]PN200-110 binding to porcine skeletal muscle dihydropyridine receptor. Biochem Biophys Res Commun 187: 894\u2013900, 1992.","DOI":"10.1016\/0006-291X(92)91281-T"},{"key":"R14","doi-asserted-by":"crossref","unstructured":"Fill M, Copello JA. Ryanodine receptor calcium release channels. Physiol Rev 82: 893\u2013922, 2002.","DOI":"10.1152\/physrev.00013.2002"},{"key":"R15","doi-asserted-by":"crossref","unstructured":"Fruen BR, Mickelson JR, Louis CF. Dantrolene inhibition of sarcoplasmic reticulum Ca2+ release by direct and specific action at skeletal muscle ryanodine receptors. J Biol Chem 272: 26965\u201326971, 1997.","DOI":"10.1074\/jbc.272.43.26965"},{"key":"R16","doi-asserted-by":"crossref","unstructured":"Gy\u00f6rke I, Gy\u00f6rke S. Regulation of the cardiac ryanodine receptor channel by luminal Ca2+ involves luminal Ca2+ sensing sites. Biophys J 75: 2801\u20132810, 1998.","DOI":"10.1016\/S0006-3495(98)77723-9"},{"key":"R17","doi-asserted-by":"crossref","unstructured":"Herland JS, Julian FJ, Stephenson DG. Halothane increases Ca2+ efflux via Ca2+ channels of sarcoplasmic reticulum in chemically skinned rat myocardium. J Physiol 426: 1\u201318, 1990.","DOI":"10.1113\/jphysiol.1990.sp018124"},{"key":"R18","doi-asserted-by":"crossref","unstructured":"Iaizzo PA, Klein W, Lehmann-Horn F. Fura-2 detected myoplasmic calcium and its correlation with contracture force in skeletal muscle from normal and malignant hyperthermia susceptible pigs. Pfl\u00fcgers Arch 411: 648\u2013653, 1988.","DOI":"10.1007\/BF00580861"},{"key":"R19","doi-asserted-by":"crossref","unstructured":"Karatzaferi C, de Haan A, Ferguson RA, van Mechelen W, Sargeant AJ. Phosphocreatine and ATP content in human single muscle fibres before and after maximum dynamic exercise. Pfl\u00fcgers Arch 442: 467\u2013474, 2001.","DOI":"10.1007\/s004240100552"},{"key":"R20","doi-asserted-by":"crossref","unstructured":"Kobayashi S, Bannister ML, Gangopadhyay JP, Hamada T, Parness J, Ikemoto N. Dantrolene stabilizes domain interactions within the ryanodine receptor. J Biol Chem 280: 6580\u20136587, 2005.","DOI":"10.1074\/jbc.M408375200"},{"key":"R21","doi-asserted-by":"crossref","unstructured":"Krause T, Gerbershagen MU, Fiege M, Weisshorn R, Wappler F. Dantrolene\u2013a review of its pharmacology, therapeutic use and new developments. Anaesthesia 59: 364\u2013373, 2004.","DOI":"10.1111\/j.1365-2044.2004.03658.x"},{"key":"R22","doi-asserted-by":"crossref","unstructured":"Laires MJ, Monteiro CP, Bicho M. Role of cellular magnesium in health and human disease. Front Biosci 9: 262\u2013276, 2004.","DOI":"10.2741\/1223"},{"key":"R23","doi-asserted-by":"crossref","unstructured":"Litman RS, Rosenberg H. Malignant hyperthermia: update on susceptibility testing. JAMA 293: 2918\u20132924, 2005.","DOI":"10.1001\/jama.293.23.2918"},{"key":"R24","unstructured":"Lopez JR, Alamo LA, Jones DE, Papp L, Allen PD, Gergely J, Sreter FA. [Ca2+]i in muscles of malignant hyperthermia susceptible pigs determined in vivo with Ca2+ selective microelectrodes. Muscle Nerve 9: 85\u201386, 1986."},{"key":"R25","doi-asserted-by":"crossref","unstructured":"Min JY, Meissner A, Feng X, Wang J, Malek S, Wang JF, Simon R, Morgan JP. Dantrolene: effects on abnormal intracellular Ca2+ handling and inotropy in postinfarcted rat myocardium. Eur J Pharmacol 471: 41\u201347, 2003.","DOI":"10.1016\/S0014-2999(03)01816-8"},{"key":"R26","doi-asserted-by":"crossref","unstructured":"Nelson TE, Denborough MA. Studies on normal human skeletal muscle in relation to the pathopharmacology of malignant hyperpyrexia. Clin Exp Pharmacol Physiol 4: 315\u2013322, 1977.","DOI":"10.1111\/j.1440-1681.1977.tb02628.x"},{"key":"R27","doi-asserted-by":"crossref","unstructured":"Nelson TE, Lin M, Zapata-Sudo G, Sudo RT. Dantrolene sodium can increase or attenuate activity of skeletal muscle ryanodine receptor calcium release channel. Clinical implications. Anesthesiology 84: 1368\u20131379, 1996.","DOI":"10.1097\/00000542-199606000-00013"},{"key":"R28","doi-asserted-by":"crossref","unstructured":"Nelson TE. Halothane effects on human malignant hyperthermia skeletal muscle single calcium-release channels in planar lipid bilayers. Anesthesiology 76: 588\u2013595, 1992.","DOI":"10.1097\/00000542-199204000-00016"},{"key":"R29","doi-asserted-by":"crossref","unstructured":"Ohnishi ST, Taylor S, Gronert GA. Calcium-induced Ca2+ release from sarcoplasmic reticulum of pigs susceptible to malignant hyperthermia. The effects of halothane and dantrolene. FEBS Lett 161: 103\u2013107, 1983.","DOI":"10.1016\/0014-5793(83)80739-X"},{"key":"R30","doi-asserted-by":"crossref","unstructured":"Ording H, Brancadoro V, Cozzolino S, Ellis FR, Glauber V, Gonano EF, Halsall PJ, Hartung E, Heffron JJ, Heytens L, Kozak-Ribbens G, Kress H, Krivosic-Horber R, Lehmann-Horn F, Mortier W, Nivoche Y, Ranklev-Twetman E, Sigurdsson S, Snoeck M, Stieglitz P, Tegazzin V, Urwyler A, Wappler F. In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH Group: results of testing patients surviving fulm1inant MH and unrelated low-risk subjects. The European Malignant Hyperthermia Group. Acta Anaesthesiol Scand 41: 955\u2013966, 1997.","DOI":"10.1111\/j.1399-6576.1997.tb04820.x"},{"key":"R31","doi-asserted-by":"crossref","unstructured":"Otsu K, Nishida K, Kimura Y, Kuzuya T, Hori M, Kamada T, Tada M. The point mutation Arg615\u2192Cys in the Ca2+ release channel of skeletal sarcoplasmic reticulum is responsible for hypersensitivity to caffeine and halothane in malignant hyperthermia. J Biol Chem 269: 9413\u20139415, 1994.","DOI":"10.1016\/S0021-9258(17)36895-3"},{"key":"R32","doi-asserted-by":"crossref","unstructured":"Owen VJ, Taske NL, Lamb GD. Reduced Mg2+ inhibition of Ca2+ release in muscle fibers of pigs susceptible to malignant hyperthermia. Am J Physiol Cell Physiol 272: C203\u2013C211, 1997.","DOI":"10.1152\/ajpcell.1997.272.1.C203"},{"key":"R33","doi-asserted-by":"crossref","unstructured":"Palade P. Drug-induced Ca2+ release from isolated sarcoplasmic reticulum. II Releases involving a Ca2+-induced Ca2+ release channel. J Biol Chem 262: 6142\u20136148, 1987.","DOI":"10.1016\/S0021-9258(18)45549-4"},{"key":"R34","doi-asserted-by":"crossref","unstructured":"Paul-Pletzer K, Palnitkar SS, Jimenez LS, Morimoto H, Parness J. The skeletal muscle ryanodine receptor identified as a molecular target of [3H]azidodantrolene by photoaffinity labeling. Biochemistry 40: 531\u2013542, 2001.","DOI":"10.1021\/bi001502s"},{"key":"R35","doi-asserted-by":"crossref","unstructured":"Paul-Pletzer K, Yamamoto T, Ikemoto N, Jimenez LS, Morimoto H, Williams PG, Ma J, Parness J. Probing a putative dantrolene-binding site on the cardiac ryanodine receptor. Biochem J 387: 905\u2013909, 2005.","DOI":"10.1042\/BJ20041336"},{"key":"R36","doi-asserted-by":"crossref","unstructured":"Renganathan M, Messi ML, Delbono O. Dihydropyridine receptor-ryanodine receptor uncoupling in aged skeletal muscle. J Membr Biol 157: 247\u2013253, 1997.","DOI":"10.1007\/s002329900233"},{"key":"R37","doi-asserted-by":"crossref","unstructured":"Richter M, Schleithoff L, Deufel T, Lehmann-Horn F, Herrmann-Frank A. Functional characterization of a distinct ryanodine receptor mutation in human malignant hyperthermia-susceptible muscle. J Biol Chem 272: 5256\u20135260, 1997.","DOI":"10.1074\/jbc.272.8.5256"},{"key":"R38","doi-asserted-by":"crossref","unstructured":"Robinson R, Carpenter D, Shaw MA, Halsall J, Hopkins P. Mutations in RYR1 in malignant hyperthermia and central core disease. Hum Mutat 27: 977\u2013989, 2006.","DOI":"10.1002\/humu.20356"},{"key":"R39","doi-asserted-by":"crossref","unstructured":"Saito A, Seiler S, Chu A, Fleischer S. Preparation and morphology of sarcoplasmic reticulum terminal cisternae from rabbit skeletal muscle. J Cell Biol 99: 875\u2013885, 1984.","DOI":"10.1083\/jcb.99.3.875"},{"key":"R40","doi-asserted-by":"crossref","unstructured":"Sitsapesan R, Williams AJ. The gating of the sheep skeletal sarcoplasmic reticulum Ca2+-release channel is regulated by luminal Ca2+. J Membr Biol 146: 133\u2013144, 1995.","DOI":"10.1007\/BF00238004"},{"key":"R41","doi-asserted-by":"crossref","unstructured":"Smith JS, Coronado R, Meissner G. Single channel measurements of the calcium release channel from skeletal muscle sarcoplasmic reticulum. Activation by Ca2+ and ATP and modulation by Mg2+. J Gen Physiol 88: 573\u2013588, 1986.","DOI":"10.1085\/jgp.88.5.573"},{"key":"R42","doi-asserted-by":"crossref","unstructured":"Steele DS, Duke AM. Defective Mg2+ regulation of RyR1 as a causal factor in malignant hyperthermia. Arch Biochem Biophys 458: 57\u201364, 2007.","DOI":"10.1016\/j.abb.2006.03.001"},{"key":"R43","doi-asserted-by":"crossref","unstructured":"Szentesi P, Collet C, Sarkozi S, Szegedi C, Jona I, Jacquemond V, Kovacs L, Csernoch L. Effects of dantrolene on steps of excitation-contraction coupling in mammalian skeletal muscle fibers. J Gen Physiol 118: 355\u2013375, 2001.","DOI":"10.1085\/jgp.118.4.355"},{"key":"R44","doi-asserted-by":"crossref","unstructured":"von Breunig F, Wappler F, Hagel C, von Richthofen V, Fiege M, Weisshorn R, Stavrou D, Schulte am Esch J. Histomorphologic examination of skeletal muscle preparations does not differentiate between malignant hyperthermia-susceptible and -normal patients. Anesthesiology 100: 789\u2013794, 2004.","DOI":"10.1097\/00000542-200404000-00007"},{"key":"R45","doi-asserted-by":"crossref","unstructured":"Wheeler DM, Rice RT, Hansford RG, Lakatta EG. The effect of halothane on the free intracellular calcium concentration of isolated rat heart cells. Anesthesiology 69: 578\u2013583, 1988.","DOI":"10.1097\/00000542-198810000-00019"},{"key":"R46","doi-asserted-by":"crossref","unstructured":"Yang T, Esteve E, Pessah IN, Molinski TF, Allen PD, Lopez JR. Elevated resting [Ca2+]i in myotubes expressing malignant hyperthermia RyR1 cDNAs is partially restored by modulation of passive calcium leak from the SR. Am J Physiol Cell Physiol 292: C1591\u2013C1598, 2007.","DOI":"10.1152\/ajpcell.00133.2006"},{"key":"R47","doi-asserted-by":"crossref","unstructured":"Yang T, Riehl J, Esteve E, Matthaei KI, Goth S, Allen PD, Pessah IN, Lopez JR. Pharmacologic and functional characterization of malignant hyperthermia in the R163C RyR1 knock-in mouse. Anesthesiology 105: 1064\u20131075, 2006.","DOI":"10.1097\/00000542-200612000-00016"},{"key":"R48","doi-asserted-by":"crossref","unstructured":"Yang T, Ta TA, Pessah IN, Allen PD. Functional defects in six ryanodine receptor isoform-1 (RyR1) mutations associated with malignant hyperthermia and their impact on skeletal excitation-contraction coupling. J Biol Chem 278: 25722\u201325730, 2003.","DOI":"10.1074\/jbc.M302165200"},{"key":"R49","doi-asserted-by":"crossref","unstructured":"Zhang Y, Rodney GG, Schneider MF. Effects of azumolene on Ca2+ sparks in skeletal muscle fibers. J Pharmacol Exp Ther 314: 94\u2013102, 2005.","DOI":"10.1124\/jpet.105.084046"},{"key":"R50","doi-asserted-by":"crossref","unstructured":"Zhao X, Weisleder N, Han X, Pan Z, Parness J, Brotto M, Ma J. Azumolene inhibits a component of store-operated calcium entry coupled to the skeletal muscle ryanodine receptor. J Biol Chem 281: 33477\u201333486, 2006.","DOI":"10.1074\/jbc.M602306200"},{"key":"R51","doi-asserted-by":"crossref","unstructured":"Zhou H, Jungbluth H, Sewry CA, Feng L, Bertini E, Bushby K, Straub V, Roper H, Rose MR, Brockington M, Kinali M, Manzur A, Robb S, Appleton R, Messina S, D'Amico A, Quinlivan R, Swash M, Muller CR, Brown S, Treves S, Muntoni F. Molecular mechanisms and phenotypic variation in RYR1-related congenital myopathies. Brain 130: 2024\u20132036, 2007.","DOI":"10.1093\/brain\/awm096"},{"key":"R52","doi-asserted-by":"crossref","unstructured":"Zhou J, Yi J, Royer L, Launikonis BS, Gonzalez A, Garcia J, Rios E. A probable role of dihydropyridine receptors in repression of Ca2+ sparks demonstrated in cultured mammalian muscle. Am J Physiol Cell Physiol 290: C539\u2013C553, 2006.","DOI":"10.1152\/ajpcell.00592.2004"}],"container-title":["American Journal of Physiology-Cell Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.physiology.org\/doi\/pdf\/10.1152\/ajpcell.90642.2007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T17:30:28Z","timestamp":1718645428000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.physiology.org\/doi\/10.1152\/ajpcell.90642.2007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["10.1152\/ajpcell.90642.2007"],"URL":"https:\/\/doi.org\/10.1152\/ajpcell.90642.2007","relation":{},"ISSN":["0363-6143","1522-1563"],"issn-type":[{"value":"0363-6143","type":"print"},{"value":"1522-1563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}